Female Urinary Incontinence Treatment Device Market

Female urinary incontinence is diagnosed as a condition which causes unintentional urination. Urinary incontinence or stress urinary incontinence usually occurs during physical activities such as running, sneezing, coughing, or even during lifting weights as these activities exert pressures on the urinary bladder. Urinary urge and stress incontinence are different from each other, as the former is caused when the bladder muscles are contracted. Stress urinary incontinence affects women more than men and is mostly caused due to weak sphincter muscle, which can lead to social isolation. Female urinary incontinence is of two types: first is urethral hypermobility and secondly due to intrinsic sphincter deficiency. In the case of urethra hypermobility, increasing abdominal pressure changes the position of urethra. On the other hand in intrinsic sphincter the deficiency, the sphincter has lost its ability to seal in intrinsic sphincter deficiency. Women above 60 year of age often suffer from female stress urinary incontinence due to the weakening of their pelvic muscles. Female stress urinary incontinence can also occur during pregnancy, hysterectomy, menopause, chronic disorders such as tuberculosis, congenital diseases, obesity, and anatomical predisposition.

Female Urinary Incontinence Treatment Device Market contains market size and forecasts of Female Urinary Incontinence Treatment Device in global, including the following market information:

Global Female Urinary Incontinence Treatment Device Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Female Urinary Incontinence Treatment Device Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Female Urinary Incontinence Treatment Device companies in 2021 (%)

The global Female Urinary Incontinence Treatment Device market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Urethral Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Female Urinary Incontinence Treatment Device include BD, Karl Storz, Johnson and Johnson, Coloplast, Boston Scientific, Teleflex, Medtronic, InControl Medical and Atlantic Therapeutics Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Female Urinary Incontinence Treatment Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Female Urinary Incontinence Treatment Device Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Female Urinary Incontinence Treatment Device Market Segment Percentages, by Type, 2021 (%)

Urethral Devices

Internal Vaginal Devices

Global Female Urinary Incontinence Treatment Device Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Female Urinary Incontinence Treatment Device Market Segment Percentages, by Application, 2021 (%)

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Others

Global Female Urinary Incontinence Treatment Device Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Female Urinary Incontinence Treatment Device Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Female Urinary Incontinence Treatment Device revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Female Urinary Incontinence Treatment Device revenues share in global market, 2021 (%)

Key companies Female Urinary Incontinence Treatment Device sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Female Urinary Incontinence Treatment Device sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

BD

Karl Storz

Johnson and Johnson

Coloplast

Boston Scientific

Teleflex

Medtronic

InControl Medical

Atlantic Therapeutics Group

Axonics Modulation Technologies

Laborie

Micron Medical

American Medical Solutions